Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
14 Marzo 2024 - 2:05PM
Business Wire
Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company
leveraging its novel and proprietary CellFX Nanosecond Pulsed Field
Ablation™ (nsPFA™) technology, today announced it will report
financial results for the fourth quarter and full year 2023 after
market close on Thursday, March 28, 2024. Company management will
host a corresponding conference call beginning at 1:30pm PT /
4:30pm ET.
Investors interested in listening to the conference call may do
so by dialing 1-877-704-4453 for domestic callers or 1-201-389-0920
for international callers. A live and recorded webcast of the event
will be available at http://investors.pulsebiosciences.com/.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company
committed to health innovation that has the potential to improve
the quality of life for patients. The Company’s proprietary CellFX®
nsPFA™ technology delivers nanosecond pulses of electrical energy
to non-thermally clear cells while sparing adjacent noncellular
tissue. The Company is actively pursuing the development of its
CellFX nsPFA technology for use in the treatment of atrial
fibrillation and in a select few other markets where it could have
a profound positive impact on healthcare for both patients and
providers.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA,
CellFX nsPFA and the stylized logos are among the trademarks and/or
registered trademarks of Pulse Biosciences, Inc. in the United
States and other countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240314657698/en/
Investor Contacts: Pulse Biosciences Kevin Danahy,
President and CEO 510.241.1077 IR@pulsebiosciences.com
or Gilmartin Group Philip Trip Taylor 415.937.5406
philip@gilmartinir.com
Pulse Biosciences (NASDAQ:PLSE)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Pulse Biosciences (NASDAQ:PLSE)
Gráfica de Acción Histórica
De May 2023 a May 2024